Drug Discovery and Diagnostic Development
Turning bacterial surveillance and genomic data into rapid diagnostics and new treatment options against antimicrobial-resistant bacteria, designed for health systems with limited resources.
Why it matters
Our goal
Translate our research on resistant bacteria into concrete diagnostic and therapeutic solutions adapted to resource-limited settings.
Specific objectives
What the programme sets out to achieve.
Identify bacterial targets relevant for the diagnosis and treatment of resistant infections.
Develop, test and validate rapid tests that identify resistant bacteria and guide antibiotic choice.
Explore innovative options against resistant bacteria: new antimicrobials, combinations and alternatives to antibiotics.
Support technology transfer and the valorisation of results.
Main activities
- Target identification from genomic and phenotypic data
- Prototype diagnostic tests
- In vitro studies of therapeutic candidates and alternative approaches
- Preclinical validation and pilot studies under controlled conditions
- Regulatory and scientific documentation for valorisation
Funded projects
Competitive grants carried by this programme. Click a project to open its page.
Milestones ahead
Deliverables planned under the institute’s strategic plan.
- Prioritised diagnostic and therapeutic targets
- Developed and validated diagnostic prototypes
- Preclinical results on innovative therapeutic approaches
- Technical dossiers for technology transfer and partnerships